|
1
|
Zhu W, He X, Cheng K, Zhang L, Chen D,
Wang X, Qiu G, Cao X and Weng X: Ankylosing spondylitis: Etiology,
pathogenesis, and treatments. Bone Res. 7(22)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ranganathan V, Gracey E, Brown MA, Inman
RD and Haroon N: Pathogenesis of ankylosing spondylitis-recent
advances and future directions. Nat Rev Rheumatol. 13:359–367.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Castañeda S, Martín-Martínez MA,
González-Juanatey C, Llorca J, García-Yébenes MJ, Pérez-Vicente S,
Sánchez-Costa JT, Díaz-Gonzalez F and González-Gay MA: CARMA
Project Collaborative Group. Cardiovascular morbidity and
associated risk factors in Spanish patients with chronic
inflammatory rheumatic diseases attending rheumatology clinics:
Baseline data of the CARMA Project. Semin Arthritis Rheum.
44:618–26. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Authors/Task Force Members. Piepoli MF,
Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT,
Corrà U, Cosyns B, et al: 2016 European Guidelines on
cardiovascular disease prevention in clinical practice: The Sixth
Joint Task Force of the European Society of Cardiology and Other
Societies on Cardiovascular Disease Prevention in Clinical Practice
(constituted by representatives of 10 societies and by invited
experts) Developed with the special contribution of the European
Association for Cardiovascular Prevention & Rehabilitation
(EACPR). Atherosclerosis. 252:207–274. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rocha E: Cardiovascular risk scores:
Usefulness and limitations. Rev Port Cardiol. 35:15–8.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Navarini L, Caso F, Costa L, Currado D,
Stola L, Perrotta F, Delfino L, Sperti M, Deriu MA, Ruscitti P, et
al: Cardiovascular risk prediction in ankylosing spondylitis: From
traditional scores to machine learning assessment. Rheumatol Ther.
7:867–882. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Paredes S, Rocha T, Mendes D, Carvalho P,
Henriques J, Morais J, Ferreira J and Mendes M: New approaches for
improving cardiovascular risk assessment. Rev Port Cardiol.
35:5–13. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Soulaidopoulos S, Nikiphorou E,
Dimitroulas T and Kitas GD: The role of statins in disease
modification and cardiovascular risk in rheumatoid arthritis. Front
Med (Lausanne). 5(24)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rueda-Gotor J, Genre F, Corrales A, Blanco
R, Fuentevilla P, Portilla V, Expósito R, Arnaiz CM, Pina T,
González-Juanatey C, et al: Relative risk chart score for the
assessment of the cardiovascular risk in young patients with
ankylosing spondylitis. Int J Rheumatol.
2018(1847894)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mathieu S and Soubrier M: Cardiovascular
events in ankylosing spondylitis: A 2018 meta-analysis. Ann Rheum
Dis. 78(e57)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Taurog JD, Chhabra A and Colbert RA:
Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med.
375(1303)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yuan Y, Yang J, Zhang X, Han R, Chen M, Hu
X, Ma Y, Wu M, Wang M, Xu S and Pan F: Carotid intima-media
thickness in patients with ankylosing spondylitis: A systematic
review and updated meta-analysis. J Atheroscler Thromb. 26:260–271.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bengtsson K, Klingberg E, Deminger A,
Wallberg H, Jacobsson LTH, Bergfeldt L and Forsblad-d'Elia H:
Cardiac conduction disturbances in patients with ankylosing
spondylitis: Results from a 5-year follow-up cohort study. RMD
Open. 5(e001053)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Palazzi C, Salvarani C, D'Angelo S and
Olivieri I: Aortitis and periaortitis in ankylosing spondylitis.
Joint Bone Spine. 78:451–455. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Klingberg E, Sveälv BG, Täng MS,
Bech-Hanssen O, Forsblad-d'Elia H and Bergfeldt L: Aortic
regurgitation is common in ankylosing spondylitis: Time for routine
echocardiography evaluation? Am J Med. 128:1244–1250.e1.
2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Midtbø H, Semb AG, Matre K, Rollefstad S,
Berg IJ and Gerdts E: Left ventricular systolic myocardial function
in ankylosing spondylitis. Arthritis Care Res (Hoboken).
71:1276–1283. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cozlea DL, Farcas DM, Nagy A, Keresztesi
AA, Tifrea R, Cozlea L and Carașca E: The impact of C reactive
protein on global cardiovascular risk on patients with coronary
artery disease. Curr Health Sci J. 39:225–31. 2013.PubMed/NCBI
|
|
18
|
Van der Linden S, Valkenburg HA and Cats
A: Evaluation of diagnostic criteria for ankylosing spondylitis. A
proposal for modification of the New York criteria. Arthritis
Rheum. 27:361–368. 1984.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Libby P: Inflammation in atherosclerosis.
Arterioscler Thromb Vasc Biol. 32:2045–2051. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Steven S, Frenis K, Oelze M, Kalinovic S,
Kuntic M, Bayo Jimenez MT, Vujacic-Mirski K, Helmstädter J,
Kröller-Schön S, Münzel T and Daiber A: Vascular inflammation and
oxidative stress: Major triggers for cardiovascular disease. Oxid
Med Cell Longev. 2019(7092151)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Crowson CS, Liao KP, Davis JM III, Solomon
DH, Matteson EL, Knutson KL, Hlatky MA and Gabriel SE: Rheumatoid
arthritis and cardiovascular disease. Am Heart J. 166:622–628.e1.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Marchio P, Guerra-Ojeda S, Vila JM,
Aldasoro M, Victor VM and Mauricio MD: Targeting early
atherosclerosis: A focus on oxidative stress and inflammation. Oxid
Med Cell Longev. 2019(8563845)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Montecucco F and Mach F: Common
inflammatory mediators orchestrate pathophysiological processes in
rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford).
48:11–22. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Han C, Robinson DWJ, Hackett MV, Paramore
LC, Fraeman KH and Bala MV: Cardiovascular disease and risk factors
in patients with rheumatoid arthritis, psoriatic arthritis, and
ankylosing spondylitis. J Rheumatol. 33:2167–72. 2006.PubMed/NCBI
|
|
25
|
El Maghraoui A: Extra-articular
manifestations of ankylosing spondylitis: Prevalence,
characteristics and therapeutic implications. Eur J Intern Med.
22:554–560. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
de Winter JJ, van Mens LJ, van der Heijde
D, Landewé R and Baeten DL: Prevalence of peripheral and
extra-articular disease in ankylosing spondylitis versus
non-radiographic axial spondyloarthritis: A meta-analysis.
Arthritis Res Ther. 18(196)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ozkan Y: Cardiac involvement in ankylosing
spondylitis. J Clin Med Res. 8:427–430. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dean LE, Jones GT, MacDonald AG, Downham
C, Sturrock RD and Macfarlane GJ: Global prevalence of ankylosing
spondylitis. Rheumatology (Oxford). 53:650–657. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Boonen A: Socioeconomic consequences of
ankylosing spondylitis. Clin Exp Rheumatol. 20 (Suppl 28):S23–S26.
2002.PubMed/NCBI
|
|
30
|
Frostegård J: Immunity, atherosclerosis
and cardiovascular disease. BMC Med. 11(117)2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Legge A and Hanly JG: Managing premature
atherosclerosis in patients with chronic inflammatory diseases.
CMAJ. 190:E430–E439. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lostun A, Lostun G and Hainarosie R: A
retrospective study of non-violent deaths and diagnosis
discrepancies over a period of three years. Rev Chim. 67:1587–1590.
2016.
|
|
33
|
Niiranen TJ and Vasan RS: Epidemiology of
cardiovascular disease: Recent novel outlooks on risk factors and
clinical approaches. Expert Rev Cardiovasc Ther. 14:855–869.
2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tournadre A, Mathieu S and Soubrier M:
Managing cardiovascular risk in patients with inflammatory
arthritis: Practical considerations. Ther Adv Musculoskelet Dis.
8:180–191. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shen J, Shang Q and Tam LS: Targeting
inflammation in the prevention of cardiovascular disease in
patients with inflammatory arthritis. Transl Res. 167:138–151.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Landi M, Maldonado-Ficco H, Perez-Alamino
R, Maldonado-Cocco JA, Citera G, Arturi P, Sampaio-Barros PD,
Flores Alvarado DE, Burgos-Vargas R, Santos E, et al: Gender
differences among patients with primary ankylosing spondylitis and
spondylitis associated with psoriasis and inflammatory bowel
disease in an iberoamerican spondyloarthritis cohort. Medicine
(Baltimore). 95(e5652)2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Agca R, Heslinga SC, Rollefstad S,
Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H,
Atzeni F, et al: EULAR recommendations for cardiovascular disease
risk management in patients with rheumatoid arthritis and other
forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum
Dis. 76:17–28. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Nitipir C, Orlov-Slavu C, Olaru M,
Parosanu A, Popa AM, Iaciu C, Popescu BC, Barbu MA, Pirlog C, Calu
V, et al: The Importance of dose intensity when administering
cytotoxic chemotherapy in NSCLC-A matter as actual now as in the
past. Processes. 8(936)2020.
|
|
39
|
Serban D, Smarandache AM, Cristian D,
Tudor C, Duta L and Dascalu AM: Medical errors and patient safety
culture-shifting the healthcare paradigm in Romanian hospitals. Rom
J Leg Med. 28:195–201. 2020.
|
